Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.53 USD | +1.31% | +15.81% | +33.79% |
03-20 | HC Wainwright Adjusts Tyra Biosciences Price Target to $23 From $19, Maintains Buy Rating | MT |
03-19 | Tyra Biosciences Q4 Net Loss Widens | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 973M 77.61B |
---|---|---|---|---|---|
Net income 2024 * | -109M -8.69B | Net income 2025 * | -151M -12.04B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.8
x | P/E ratio 2025 * |
-7.67
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.84% |
Latest transcript on Tyra Biosciences, Inc.
1 day | +1.31% | ||
1 week | +15.81% | ||
Current month | +8.36% | ||
1 month | +9.77% | ||
3 months | +42.43% | ||
6 months | +56.11% | ||
Current year | +33.79% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Bensen
FOU | Founder | 49 | 01/08/18 |
Todd Harris
FOU | Founder | 44 | 01/08/18 |
Alan Fuhrman
DFI | Director of Finance/CFO | 67 | 31/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert More
CHM | Chairman | 56 | 31/10/18 |
Gilla Kaplan
BRD | Director/Board Member | 76 | 28/02/19 |
Isan Chen
BRD | Director/Board Member | 61 | 31/01/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +5.77% | - | |
0.00% | 18 M€ | +2.75% | - | |
0.00% | 34 M€ | +2.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 18.53 | +1.31% | 105,103 |
01/05/24 | 18.29 | +6.96% | 245,073 |
30/04/24 | 17.1 | +3.95% | 71,806 |
29/04/24 | 16.45 | +4.98% | 117,434 |
26/04/24 | 15.67 | +3.71% | 77,292 |
Delayed Quote Nasdaq, May 02, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.79% | 961M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- TYRA Stock